Related Experiment Videos
Comorbidity in operable lung cancer: a multicenter descriptive study on 2992 patients
1Pneumology Service, Hospital Universitario 12 de Octubre, Ctta. Andalucía 5.4, 28041 Madrid, Spain. lencuent@h12o.es
Lung Cancer (Amsterdam, Netherlands)
|February 15, 2002
Summary
Comorbidity is common in operable lung cancer (LC), with chronic obstructive pulmonary disease (COPD) being the most frequent. Older patients and those with specific symptoms show higher comorbidity rates.
Area of Science:
- Pulmonology
- Oncology
- Epidemiology
Background:
- Comorbidity significantly impacts treatment decisions and outcomes in patients with operable lung cancer (LC).
- Understanding the prevalence of comorbidities in LC is crucial for comprehensive patient management.
Purpose of the Study:
- To determine the global frequency of diseases associated with operable lung cancer (LC).
- To analyze the relationship between comorbidities, clinical symptoms, and age in operable LC patients.
Main Methods:
- A prospective, multi-institutional study involving 2,992 consecutive patients with operable LC.
- Data collected from 19 Spanish hospitals between 1993 and 1997.
- Standardized forms were used to record the presence or absence of specific comorbidities at the time of treatment.
Main Results:
- 73% of patients had one or more comorbidities, with chronic obstructive pulmonary disease (COPD) being the most frequent (50%).
- Asymptomatic patients were more likely to have a previous tumor, hypertension, or cardiac disease.
- Symptomatic patients more frequently had COPD, and comorbidity increased significantly with age.
Conclusions:
- Operable lung cancer frequently co-occurs with other diseases, most commonly COPD.
- Comorbidity patterns differ between symptomatic and asymptomatic patients, potentially due to screening bias.
- Advanced age is associated with a significant increase in the frequency of all evaluated comorbidities.